Total lymphoid irradiation in multiple sclerosis.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  1994-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp.57.2.154PMID 8126497PMCID PMC1072441
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Total Lymphoid Irradiation in Multiple Sclerosis

  1992cited by this paper
• Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis

  1992cited by this paper
• Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.

  1992cited by this paper
• Overview of azathioprine treatment in multiple sclerosis.

  1991cited by this paper
• A placebo‐controlled, double‐blind, randomized, two‐center, pilot trial of Cop 1 in chronic progressive multiple sclerosis

  1991cited by this paper
• Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

  1991cited by this paper
• Multiple sclerosis: a pivotal role for the T cell in lesion development

  1991cited by this paper
• The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.

  1991cited by this paper
• Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.

  1990cited by this paper
• Deaths after total lymphoid irradiation for multiple sclerosis.

  1989cited by this paper
• MS: a CNS and systemic autoimmune disease.

  1989cited by this paper
• Randomised double blind controlled trial of cyclosporin in multiple sclerosis.

  1989cited by this paper
• Deaths after total lymphoid irradiation for multiple sclerosis.

  1989cited by this paper
• MS: a localized immune disease of the central nervous system.

  1989cited by this paper
• Multiple sclerosis: a localised immune disease of the central nervous system

  1989cited by this paper
• Consequences and treatment of ovarian failure after total body irradiation for leukaemia.

  1989cited by this paper
• Treatment of lupus nephritis with total lymphoid irradiation. Observations during a 12-79-month followup.

  1988cited by this paper
• Effect of total lymphoid irradiation on functional status in chronic multiple sclerosis: Importance of lymphopenia early after treatment—The pros

  1988cited by this paper
• Double-masked trial of azathioprine in multiple sclerosis. British and Dutch Multiple Sclerosis Azathioprine Trial Group.

  1988cited by this paper
• Total lymphoid irradiation.

  1987cited by this paper
• The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study.

  1987cited by this paper
• Lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized study comparing 750-rad treatment with 2,000-rad treatment.

  1986cited by this paper
• Effect of total lymphoid irradiation in chronic progressive multiple sclerosis.

  1986cited by this paper
• Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized trial.

  1985cited by this paper
• Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized trial

  1985cited by this paper
• Chronic progressive multiple sclerosis

  1985cited by this paper
• Total Lymphoid Irradiation in Chronic Progressive Multiple Sclerosis: A Preliminary Report

  1984cited by this paper
• Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

  1983cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper
• Total lymphoid irradiation.

  1983cited by this paper
• Rating neurologic impairment in multiple sclerosis

  1983cited by this paper
• Fractionated Total Lymphoid Irradiation as Preparative Immunosuppression in High Risk Renal Transplantation: Clinical and Immunological Studies

  1982cited by this paper
• Treatment of intractable rheumatoid arthritis with total lymphoid irradiation.

  1981cited by this paper
• Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis.

  1981cited by this paper
• A modified card sorting test sensitive to frontal lobe defects.

  1976cited by this paper

• Primary progressive multiple sclerosis in Iran: A consensus recommendation for diagnosis and management.

  2018cites this paper
• Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives

  2017cites this paper
• Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives.

  2015cites this paper
• Progressive multiple sclerosis 3 Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives

  2015cites this paper
• Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review

  2015cites this paper
• The sad plight of multiple sclerosis research (low on fact, high on fiction): critical data to support it being a neurocristopathy

  2010cites this paper
• Multiple Sclerosis, Lymphoma and Nasopharyngeal Carcinoma: The Central Role of Epstein-Barr Virus?

  2009cites this paper
• Use of ‘sham’ radiotherapy in randomized clinical trials

  2008cites this paper
• Multiple Sclerosis and Demyelinating Diseases

  2007cites this paper
• Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis

  2005cites this paper
• Evaluation of the quality of radiotherapy randomized trials for painful bone metastases

  2005cites this paper
• Chapter 53 – Multiple Sclerosis

  2003cites this paper
• Pharmacological methods to overcome IFN-β antibody formation in the treatment of multiple sclerosis

  2003cites this paper
• Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores.

  2003cites this paper
• THE PATHOGENESIS OF MULTIPLE SCLEROSIS REVISITED

  2002cites this paper
• Multiple Sclerosis: Ethics, Outcome Variables and Clinical Scales

  2001cites this paper
• [Therapeutic indications targeting etiology of progressive multiple sclerosis].

  2001cites this paper
• Implementation of a blood irradiation program at a community cancer center

  2001cites this paper
• The immunological basis of current and novel therapies of multiple sclerosis.

  1999cites this paper
• Multiple sclerosis: Immunotherapy

  1999cites this paper
• Disease Modifying Treatments for Multiple Sclerosis

  1999cites this paper
• Review of the Results of Previous Phase II, Magnetic Resonance Imaging-monitored Clinical Trials

  1999cites this paper
• Current immunotherapy in multiple sclerosis

  1998cites this paper
• [Non-specific immunosuppression and multiple sclerosis].

  1998cites this paper
• The management of multiple sclerosis: current and future therapies.

  1998cites this paper
• A 21 Point Unifying Hypothesis on the Etiology and Treatment of Multiple Sclerosis

  1998cites this paper
• Value of magnetic resonance imaging in assessing efficacy in clinical trials of multiple sclerosis therapies.

  1997cites this paper
• A reproducible repositioning method for serial magnetic resonance imaging studies of the brain in treatment trials for multiple sclerosis

  1997cites this paper
• Modified total lymphoid irradiation and low dose corticosteroids in progressive multiple sclerosis.

  1997cites this paper
• Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

  1997cites this paper
• The effect of total lymphoid irradiation and low-dose steroids on T lymphocyte populations in multiple sclerosis: correlation with clinical and MRI status.

  1997cites this paper
• Lesion load quantification in serial MR of early relapsing multiple sclerosis patients in azathioprine treatment. A retrospective study.

  1997cites this paper
• New treatments for multiple sclerosis: a clinical perspective

  1996cites this paper
• Multiple sclerosis: a review of existing therapy and future prospects.

  1996cites this paper
• The Emergence of Multiple Sclerosis as a “Treatable” Condition; An Historical Perspective

  1996cites this paper
• Multiple sclerosis: Immune mechanism and update on current therapies

  1995cites this paper
• Correlations between changes in disability and T2‐weighted brain MRI activity in multiple sclerosis

  1995cites this paper
• Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis.

  1995cites this paper
• The treatment of multiple sclerosis: current and future.

  1995cites this paper
• Aspects physiopathologiques, cliniques, thérapeutiques et actuels de la sclérose en plaques

  1995cites this paper
• Magnetic resonance imaging and spectroscopy in multiple sclerosis.

  1995cites this paper
• Immunotherapy for multiple sclerosis.

  1994cites this paper
• Recent Advances: Neurology

  1994cites this paper
• Effect of brain irradiation on demyelinating lesions

  1993cites this paper